State of Alaska, Department of Revenue

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1370102 JUNEAU, AK

Position in PTGX

as of Mar 31, 2026 · filed Apr 20, 2026 Compact

Position Value

$3,915,293

+$587,728 QoQ

Shares Held

37,147

-2.5% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

State of Alaska, Department of Revenue holds $92,461,767 across 47 Biotechnology names. PTGX ranks #6 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	33,180	$14,816,196
2	REGN	Regeneron Pharmaceuticals, Inc.	18,363	$14,187,988
3	HALO	Halozyme Therapeutics, Inc.	157,004	$10,147,168
4	JAZZ	Jazz Pharmaceuticals plc	42,042	$7,948,040
5	KRYS	Krystal Biotech, Inc.	17,484	$4,516,465
6	PTGX	Protagonist Therapeutics, Inc This page	37,147	$3,915,293
7	PTCT	Ptc Therapeutics, Inc.	44,098	$3,004,396
8	TGTX	Tg Therapeutics, Inc.	86,343	$2,868,314

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,915,293	37,147	-2.5%	Shares	Sole	2026-04-20
2025-12-31	$3,327,565	38,099	+29.5%	Shares	Sole	2026-01-23
2025-09-30	$1,954,702	29,425	-20.3%	Shares	Sole	2025-10-24
2025-06-30	$2,039,794	36,906	+11.8%	Shares	Sole	2025-07-16
2025-03-31	$1,596,992	33,023	-2.5%	Shares	Sole	2025-04-21
2024-12-31	$1,307,420	33,871	+0.8%	Shares	Sole	2025-01-27
2024-09-30	$1,512,675	33,615	—	Shares	Sole	2024-10-24
No filing history on record for this holder in this stock.